|
|
|
|
|
|
|
|
|
|
|
Author |
Message |
|
|
Thu May 19, 2005 12:00 pm |
L'Oreal to Buy SkinCeuticals
PARIS — L'Oreal is set to snap up a new derm concern.
The French beauty giant said Wednesday it has signed a deal to acquire U.S. professional treatment brand SkinCeuticals. The Dallas-based brand's distribution network comprises dermatologists' and plastic surgeons' offices as well as spas.
"The acquisition of SkinCeuticals allows L'Oreal to strengthen its position in high-performance, professional skin care," stated L'Oreal's chairman and chief executive officer, Lindsay Owen-Jones. "This market, in which SkinCeuticals is a leading player, is a particularly promising one with high international potential."
"SkinCeuticals has already acquired an excellent reputation in the U.S. dermatological world," stated Jean-Paul Agon, president and ceo of L'Oreal USA. "This acquisition will also allow L'Oreal to enter the strong and growing market of high-end spas in the U.S."
SkinCeuticals will become part of L'Oreal's Active Cosmetics Division, which already includes the Vichy, La Roche-Posay and Inneov brands. Founded in 1994, the privately held firm had sales of $35 million last year.
The deal will be finalized "upon the customary closing conditions, including antitrust clearance," according to L'Oreal.
— Brid Costello |
|
|
|
|
Thu May 19, 2005 2:34 pm |
interesting news belle....thanks for posting that |
_________________ Combination - dehyrdated, acne, sensitive, late 20's. |
|
|
Fri Apr 19, 2024 2:59 pm |
If this is your first visit to the EDS Forums please take the time to register. Registration is required for you to post on the forums. Registration will also give you the ability to track messages of interest, send private messages to other users, participate in Gift Certificates draws and enjoy automatic discounts for shopping at our online store. Registration is free and takes just a few seconds to complete.
Click Here to join our community.
If you are already a registered member on the forums, please login to gain full access to the site. |
|
|
|
|
|